The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

From software to AI, Europe has fallen behind in creating global technology companies, hurting the economy.

which aids biotech companies in growing, attracting venture capital, and accelerating drug development. Analysts predict that a rate decline might free up billions of dollars in investment money ...

Unlike many unprofitable biotech companies, Regeneron was in the ... Dupixent was approved in Europe in the fourth quarter for the skin condition prurigo nodularis. For 2024, Sanofi is planning ...

Since its launch, the fund has screened over 300 projects and made several key investments into new companies across Europe driving cutting-edge innovation in biotechnology. Among the newly ...

The firm had licensed the right to commercialize the new drug in North America and Europe. At the time, though experts said it was a watershed moment for Chinese pharmaceutical companies ...

Amid Washington's efforts to repatriate drug production to its soil, pharmaceutical companies have not hesitated to highlight Europe's weaknesses compared to its rival. "The US now leads Europe on ...